Hybrid)

BoehringerPRD•Brampton, ON

27d•$200,000 - $394,000•Hybrid

About The Position

The Medical Affairs Strategy Team Member is responsible for creating the Medical strategic framework and prioritized medical tactics to ensure the success of the respective Beohringer Ingelheim product(s) from a Medical Affairs perspective. This individual will exhibit strong understanding of the therapeutic area, the US healthcare landscape, the relevant clinical practice guidelines, and the emerging scientific data as well as the understanding of the overall TA aspirations and value drivers. The position holder will translate the TA priorities into an integrated strategic medical plan, tactics with emphasis on evidence analysis and generation. It's important this person has experience with Rheumatology, Interstitial Lung Disease (ILD), Progressive Pulonary Fibrosis (PPF), Idiopathic Pulmonary Fibrosis (IPF), Systemic Sclerosis (SSc), and/or Myositis. This Medical Affairs Strategy role may be hired at the level for Senior Associate Director or Director, depending on the experience and education of the selected candidate as well as business need. This role is an on-site/flex role, which means it must work from the Ridgefield, Connecticut office 2-3 days per week. The incumbent will work cross functionally and within the larger Clinical Development & Medical Affairs (CDMA) department (e.g., Medical Excellence, RWE, etc.) as well as across the organization (e.g., Marketing, Market Access, Analytics & Insights (A&I), HEOR, Clinical Operations, Patient Services, Legal, Compliance, etc.) and with global counterparts to create, execute, measure, and adapt the Medical Affairs strategy. As an employee of Boehringer Ingelheim, you will actively contribute to the discovery, development, and delivery of our products to our patients and customers. Our global presence provides opportunities for all employees to collaborate internationally, offering visibility and opportunity to directly contribute to the companies' success. We realize that our strength and competitive advantage lie with our people. We support our employees in several ways to foster a healthy working environment, meaningful work, mobility, networking, and work-life balance. Our competitive compensation and benefit programs reflect Boehringer Ingelheim's high regard for our employees.

Requirements

Bachelor’s degree required, and in addition fulfill one of the following education levels: Advanced degree (PharmD, NP, PA, Master’s, M.D., DO, Ph.D.), Combined Bachelor of Science with a MBA, or BSN with an MBA, Other medically qualified licensure (e.g., RPh, Respiratory Therapist).
Seven (7) years of professional experience in a scientific, clinical, and/or medical space, including five (5) years in relevant position in pharmaceutical or related industry (for Sr. Associate Director).
One-plus (1+) years’ experience in Medical Affairs, Clinical Trials, Regulatory, or related area supporting relevant Therapeutic area (for Sr. Associate Director).
Ten (10) years of professional experience in a scientific, clinical, and/or medical space, including seven (7) years in relevant position in pharmaceutical or related industry (for Director).
Three-plus (3+) years’ experience in Medical Affairs supporting relevant Therapeutic area (for Director).
Experience in Rheumatology would be strongly preferred (to include ILD, PPF, IPF, SSc and/or Myositis)
Demonstrated experience with pharmaceutical drug development and the use of data analysis for strategy development, business process improvement, product launch planning, and integrated evidence generation.
Ability to collaborate, influence, and lead with executive presence, establishing strategic direction, drive execution, create compelling communications and provide a global perspective.
Ability to translate scientific and medical market insights into medical tactical plans, integrated evidence generation plans, and optimized medical strategies.
Demonstrated ability to collaborate cross-functionally to enable successful execution and deliver results in a deadline-driven environment while managing multiple priorities.
Deep understanding of therapeutic area(s), shifting US healthcare environment, medical, pharmaceutical and payor market dynamics, portfolio growth, and ability to manage multiple projects and identify risks in a fast-paced environment with a drive for results and sense of urgency to meet medical market needs.
Ability to travel with some overnights away from home as required by the nature of the role.
Must be legally authorized to work in the United States without restriction.
Must be willing to take a drug test and post-offer physical (if required).
Must be 18 years of age or older.

Responsibilities

Leads the indication- or product-specific co-creation with corporate partners of the relevant Global Integrated Business Plans (IBPs) and ensure US strategic business needs are fully integrated into the global IBPs.
Leads the creation of the respective US Medical Affairs Plans (MAP’s) and implement Launch Excellence tactics in Medical Affairs by driving robust TA medical dialogue with the Corporate TA stakeholders, the US Launch Lead, RWE, FBM, and Medical Excellence.
Effectively drives the execution of medical tactics, key data release activities, stay abreast of paradigm shifts in clinical practice, and align with BI / CDMA objectives, clinical development pipeline and the evolving US healthcare landscape.
Identifies and promotes synergies throughout the product lifecycle by influencing the US TAs, Corporate medical, the US TA franchise, Commercial operations, Go-To-Market (GTM), and CDMA leaders.
Proactively partners with the Medical Affairs Strategy Executive Director to ensure the seamless collaboration with the Clinical Development Lead and the Early Asset TA Lead to facilitate the full integration of the prioritized US clinical practice dynamics into the Clinical Development programs.
Drives success in TA launches and the timely execution of prioritized evidence generation programs in collaboration with Corporate Medicine TA and US franchise leadership.
Serves as a key representative in strategic discussions with TAs and CDMA Leadership regarding TA products to maximize business opportunities from a medical perspective, identify risks, assess the competitive landscape, and ensure appropriate collaboration occur with various business functions.
Leads the integration of insights, planning, execution, and analysis of evidence programs, creation, and enhancement of content resources, maximizing medical communication channels and Strategic Engagement program with key experts, scientific leaders, and key institutions.
Ensures strategic congress planning, medical education, advisory boards, publication strategies, scientific advancement grants, and interface with professional societies relevant to the TA products.
Ensures availability of prioritized content, as well as develops and tracks the associated agreed measurable business outcomes. Proactively engages with Medical Customer Experience, A&I, and Capability Excellence teams to ensure seamless planning.
Actively contributes at and represents the CDMA TA team in internal business planning workshops and relevant strategic planning governance regarding TA products to ensure effective co-creation of appropriate, aligned, and integrated critical success factors, strategic imperatives, and their associated outcome measures (e.g., key performance indicators, metrics).
Leads proactive and ad hoc TA specific US projects to drive key strategic initiatives that facilitate business agility, customer focus and ensure compliance standards are met.
Leverages CDMA resources to create tailored tools and material to address organized customers, Payers/Systems in support of the Account Medical Advisors (AMA's).
Co-creates an aligned strategic framework for organized customers in collaboration with the Value/Access and Health-Systems marketing teams.
Ensures coordinated communication plan for Payers/Systems across the relevant internal stakeholders with emphasis on leading the medical affairs aspects of these plans.
Drives the US collaboration with Corporate TA’s to create a consolidated medical strategy and integrated evidence plan for TA's products/indications that prioritize innovation and address meaningful gaps internally and externally.